1. Home
  2. PRO vs EYPT Comparison

PRO vs EYPT Comparison

Compare PRO & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRO
  • EYPT
  • Stock Information
  • Founded
  • PRO 1985
  • EYPT 1987
  • Country
  • PRO United States
  • EYPT United States
  • Employees
  • PRO N/A
  • EYPT N/A
  • Industry
  • PRO EDP Services
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PRO Technology
  • EYPT Industrials
  • Exchange
  • PRO Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • PRO 761.5M
  • EYPT 741.0M
  • IPO Year
  • PRO 2007
  • EYPT 2005
  • Fundamental
  • Price
  • PRO $22.95
  • EYPT $13.24
  • Analyst Decision
  • PRO Buy
  • EYPT Strong Buy
  • Analyst Count
  • PRO 9
  • EYPT 6
  • Target Price
  • PRO $26.53
  • EYPT $25.83
  • AVG Volume (30 Days)
  • PRO 2.4M
  • EYPT 1.1M
  • Earning Date
  • PRO 10-28-2025
  • EYPT 11-06-2025
  • Dividend Yield
  • PRO N/A
  • EYPT N/A
  • EPS Growth
  • PRO N/A
  • EYPT N/A
  • EPS
  • PRO N/A
  • EYPT N/A
  • Revenue
  • PRO $342,708,000.00
  • EYPT $51,898,000.00
  • Revenue This Year
  • PRO $10.33
  • EYPT N/A
  • Revenue Next Year
  • PRO $10.76
  • EYPT N/A
  • P/E Ratio
  • PRO N/A
  • EYPT N/A
  • Revenue Growth
  • PRO 7.96
  • EYPT 2.99
  • 52 Week Low
  • PRO $13.61
  • EYPT $3.91
  • 52 Week High
  • PRO $29.84
  • EYPT $14.91
  • Technical
  • Relative Strength Index (RSI)
  • PRO 82.86
  • EYPT 51.60
  • Support Level
  • PRO $22.90
  • EYPT $12.54
  • Resistance Level
  • PRO $22.99
  • EYPT $14.04
  • Average True Range (ATR)
  • PRO 0.15
  • EYPT 0.86
  • MACD
  • PRO 0.14
  • EYPT -0.13
  • Stochastic Oscillator
  • PRO 98.69
  • EYPT 24.05

About PRO PROS Holdings Inc.

Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: